Skip to content

Natrelle Inspira SoftTouch Breast Implants TSX-340Recalls & reported problems

Allergan, Inc. · Natrelle Inspira TSX 340cc Extra Full profile BIOCELL |textured|round|silicone · Class 3 · Implant

All models of Natrelle Breast Implants (1167) · Natrelle Inspira SoftTouch Breast Implants (195)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
8
Deaths reported
0
Injuries reported
8
Recalls naming it
1

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 10888628034310), received between Jan 20, 2021 and Sep 5, 2026 — classified as 8 injuries.

The most frequently reported specific device problem is “Device Appears to Trigger Rejection” (5 reports).

1 FDA recall record name this device's identifier, 1 still open.

3 other recalls cover devices cleared under the same FDA submission (P020056); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 2 reportsJul 2025: 2 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 1 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 1 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Jul 24, 2019Open, Classified

    The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.

    Z-2453-2019 · Root cause: Unknown/Undetermined by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Device Appears to Trigger Rejection5
  • Material Rupture3
  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Capsular Contracture5
  • Failure of Implant2
  • Anxiety1
  • No Clinical Signs, Symptoms or Conditions1
  • Pain1
  • Seroma1
  • Swelling/ Edema1

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • InjurySep 5, 2026Material Rupture

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50625533 ↗
  • InjuryJun 25, 2026Device Appears to Trigger Rejection; Adverse Event Without Identified Device or Use Problem

    PATIENT REPORTED "PERSISTENT PAIN", "BREAST SWELLING", "PHYSICAL DISCOMFORT" AND "ANXIETY ATTACKS" AGAINST THE LEFT SIDE. THE DEVICE REMAINS IMPLANTED.

    Patient problems: Anxiety; Capsular Contracture; Pain; Swelling/ Edema

    MAUDE report 25620173 ↗
  • InjuryJul 8, 2025Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    PATIENT REPRESENTATIVE REPORTS "PATIENT'S LEFT BREAST SWELLED, IT WAS 3 TIMES LARGER THAN IT WAS". PATIENT "DRAINED THE FLUID AND TOOK ANTI INFLAMMATORY." THIRD PARTY LAWYER LATER REPORTED "THE PATIENT WAS SURPRISED BY THE NEWS OF A WORLDWIDE RECALL OF ALLERGAN BREAST IMPLANTS DUE TO THE HIGH RISK OF DEVELOPING A RARE TYPE OF CANCER - ANAPLASTIC LYMPHOMA, DIRECTLY ASSOCIATED WITH THE TEXTURED SURFACE OF THE IMPLANTS" "THE SITUATION CAUSED IMMENSE ANGUISH, FEAR AND EMOTIONAL INSTABILITY FOR THE PATIENT, WHO WAS FORCED TO SEEK IMMEDIATE PHYSICIAN ASSISTANCE." ¿IT EVOLVED WITH BAKER IV CAPSULAR CONTRACTURE AND DISTORTION OF THE SHAPE OF THE BREASTS¿. "THE PATIENT DEVELOPED BAKER IV CAPSULAR CONTRACTURE AND DISTORTION OF THE SHAPE OF HER BREASTS." THIS IS FOR THE LEFT SIDE DEVICE. THE DEVICE REMAINS IMPLANTED.

    Patient problems: Capsular Contracture; Seroma

    MAUDE report 22444124 ↗
  • InjuryJul 8, 2025Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    PATIENT REPRESENTATIVE REPORTED "THE PATIENT WAS SURPRISED BY THE NEWS OF A WORLDWIDE RECALL OF ALLERGAN BREAST IMPLANTS DUE TO THE HIGH RISK OF DEVELOPING A RARE TYPE OF CANCER - ANAPLASTIC LYMPHOMA, DIRECTLY ASSOCIATED WITH THE TEXTURED SURFACE OF THE IMPLANTS", "THE SITUATION CAUSED IMMENSE ANGUISH, FEAR AND EMOTIONAL INSTABILITY FOR THE PATIENT, WHO WAS FORCED TO SEEK IMMEDIATE PHYSICIAN ASSISTANCE", ¿IT EVOLVED WITH BAKER IV CAPSULAR CONTRACTURE AND DISTORTION OF THE SHAPE OF THE BREASTS¿. AFFECTED SIDE IS RIGHT. THE DEVICE REMAINS IMPLANTED.

    Patient problems: Capsular Contracture

    MAUDE report 22437406 ↗
  • InjuryJun 4, 2025Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    HEALTHCARE PROFESSIONAL REPORTED RIGHT SIDE "EXCHANGE FROM TEXTURED TO SMOOTH DEVICES DUE TO THE PATIENTS CONCERN" AND "CAPSULAR CONTRACTURE BAKER GRADE III". THE DEVICE REMAINS IMPLANTED.

    Patient problems: Capsular Contracture

    MAUDE report 22144590 ↗
  • InjuryJun 4, 2025Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    HEALTHCARE PROFESSIONAL REPORTED " EXCHANGE FROM TEXTURED TO SMOOTH DEVICES DUE TO THE PATIENTS CONCERN." AND " BILATERAL CAPSULAR CONTRACTURE BAKER GRADE III". THIS RECORD IS FOR THE "LEFT" SIDE. THE DEVICE REMAINS IMPLANTED.

    Patient problems: Capsular Contracture

    MAUDE report 22144296 ↗
  • InjuryJan 21, 2021Material Rupture; Material Rupture

    PATIENT ADDITIONALLY REPORTED RIPPLED IMPLANT, BURNING/ITCHING FEELING, LOST OF FEELING/COMPLETELY NUMB, VERY SENSITIVE, AND SHARP SHOOTING PAIN.

    Patient problems: Failure of Implant

    MAUDE report 11206719 ↗
  • InjuryJan 20, 2021Material Rupture; Material Rupture

    PATIENT ADDITIONALLY REPORTED RIPPLED IMPLANT, BURNING/ITCHING FEELING, LOSS OF FEELING/COMPLETELY NUMB, VERY SENSITIVE, AND SHARP SHOOTING PAIN.

    Patient problems: Failure of Implant

    MAUDE report 11205620 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P020056. One submission often covers many models, so check the product and lot details in each record.

  • Z-0701-2020 · Nov 6, 2019 · Terminated
    Natrelle Inspira Sillicone-Filled Breast Implants for the following Styles and Sizes: 7607 SSM, 7608 SSF, 7609 SSX, 7513 SRL, 7514 SRLP, 7515 SRM, 7516 SRF, 7517 SRX, 7626 SCL, 762
  • Z-0700-2020 · Nov 6, 2019 · Terminated
    Natrelle Silicone Filled Breast Implants for the following Styles and Sizes: Style 10, Style 15, Style 20, Style 40, Style 45 Style 10/UDI: NATRELLE Style 10-180 Gel Round Mod 108
  • Z-2454-2019 · Jul 24, 2019 · Open, Classified
    Natrelle and McGhan Silicone-Filled Breast Implant BioCell Round Moderate Profile, Sterile, for the following style numbers: Style 110:110-090, 110-120, 110-150, 110-180, 110-210,

Other Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled devices

All Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page